Menu
Montecito
American Riviera
Loading...
You are here:  Home  >  Biotech  -  Page 2
Latest

Atara reports growing losses, but plenty of cash left

By   /  Friday, November 5th, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Atara reports growing losses, but plenty of cash left

Atara Biotherapeutics continued seeing losses in the third quarter of fiscal year 2021, but has enough cash on hand to remain solvent as it awaits news on its tab-cel therapy treatment in early 2022. Atara, a South San Francisco-based immunotherapy based company with major operations in Westlake Village, reported net losses of $84.7 million in Read More →

Read More →
Latest

Amgen reports revenue growth in Q3 but lowers full-year guidance

By   /  Tuesday, November 2nd, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, middle, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen reports revenue growth in Q3 but lowers full-year guidance

Sales increases across Amgen’s drug lineup drove increases in revenue and non-GAAP earnings at the Thousand Oaks biotech company during the third quarter, according to its Nov. 2 earnings release, but pandemic issues persist, and the company lowered its revenue guidance for the year. Amgen, one of the largest biotech companies in the world, reported Read More →

Read More →
Latest

MannKind shares drop 18% after FDA says it will pass on new blood pressure drug

By   /  Monday, October 18th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, left, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on MannKind shares drop 18% after FDA says it will pass on new blood pressure drug

Shares of Westlake Village-based MannKind Corp. dropped 18% on Oct. 18, after the U.S. Food and Drug Administration did not approve a hypertension treatment the company is developing with United Therapeutics. In a complete letter response, the FDA declined to approve a new drug application for Tyvasio DPI, a treatment being developed by MannKind and Read More →

Read More →
Latest

Amgen’s investment in Neumora marks a return to neuroscience research

By   /  Friday, October 15th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s investment in Neumora marks a return to neuroscience research

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen goes full speed ahead on biosimilar drugs

By   /  Friday, October 15th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, middle, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen goes full speed ahead on biosimilar drugs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen invests $100M in startup pursuing brain treatments

By   /  Thursday, October 7th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, left, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen invests $100M in startup pursuing brain treatments

An Amgen-funded biotech company launched Oct. 7, announcing a strategic partnership between the two companies that includes $100 million in funding and global rights to develop and sell some of Amgen’s experimental drugs for neurodegenerative diseases. Thousand Oaks-based Amgen, one of the largest biotech companies in the world, committed $100 million in equity investment to Read More →

Read More →
Latest

Amgen wins patent case

By   /  Tuesday, September 21st, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, Law, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen wins patent case

Thousand Oaks-based Amgen had a big win in court on Sept. 20, as a federal court in New Jersey upheld multiple Amgen patents for its psoriasis treatment, Otezla. Amgen filed a patent infringement lawsuit earlier this year against two companies, Sandoz and Zydus Pharmaceuticals, claiming that their generic versions of Otezla infringed upon at least Read More →

Read More →